Northern Trust
CCEL icon

Northern Trust’s Cryo-Cell International CCEL Stock Holding History

Northern Trust’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,716
Closed -$98.8K – 4421
2025
Q4 		$98.8K Hold
28,716
– – ﹤0.01% 4141
2025
Q3 		$133K Sell
28,716
-8,298
-22% -$39.4K ﹤0.01% 4070
2025
Q2 		$192K Buy
37,014
+298
+0.8% +$1.57K ﹤0.01% 3948
2025
Q1 		$234K Sell
36,716
-2,186
-6% -$15.9K ﹤0.01% 3885
2024
Q4 		$288K Buy
38,902
+17,066
+78% +$129K ﹤0.01% 3859
2024
Q3 		$139K Sell
21,836
-362
-2% -$2.5K ﹤0.01% 3983
2024
Q2 		$169K Sell
22,198
-1,180
-5% -$9.77K ﹤0.01% 3914
2024
Q1 		$174K Sell
23,378
-2,922
-11% -$16.5K ﹤0.01% 3939
2023
Q4 		$151K Buy
+26,300
New +$136K ﹤0.01% 3999

Other funds holding CCEL

SA
SFI Advisors Montclair, New Jersey $116M AUM 37.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust's CCEL Position: Q1 2026 in Review

Northern Trust sold out of Cryo-Cell International (CCEL) in Q1 2026, closing a stake of 28,716 shares — an estimated $98.8K sold.

Northern Trust first reported a position in CCEL in Q4 2023 and held it in 9 quarters. The position peaked at $288K in Q4 2024. 11 funds tracked by Wall St. Rank hold CCEL as of Q1 2026.

  • Northern Trust reported no remaining Cryo-Cell International position as of Q1 2026 after selling out during the quarter.
  • Northern Trust sold 28,716 Cryo-Cell International shares in Q1 2026, an estimated $98.8K.
  • Northern Trust first reported a position in Cryo-Cell International in Q4 2023 and held it in 9 quarters.
  • Northern Trust's Cryo-Cell International position peaked at $288K in Q4 2024.
  • 11 funds tracked by Wall St. Rank held Cryo-Cell International as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.